InterCure (NASDAQ:INCR) Shares Scheduled to Reverse Split on Monday, August 24th

InterCure Ltd. (NASDAQ:INCR) shares are going to reverse split on Monday, August 24th. The 1-5 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, August 23rd.

InterCure Trading Down 2.1%

NASDAQ INCR opened at $0.93 on Thursday. InterCure has a 12-month low of $0.68 and a 12-month high of $1.71. The company has a fifty day simple moving average of $0.97 and a two-hundred day simple moving average of $0.89. The company has a current ratio of 1.48, a quick ratio of 0.97 and a debt-to-equity ratio of 0.20. The stock has a market cap of $50.85 million, a P/E ratio of 31.00 and a beta of 1.40.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised InterCure from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, InterCure currently has a consensus rating of “Sell”.

InterCure Company Profile

InterCure Ltd is an Israel-based medical cannabis company publicly listed on the Nasdaq Capital Market under the ticker INCR. The company’s operations span the entire value chain of medical cannabis, from the development of proprietary seed strains and controlled cultivation in a GMP-compliant facility to laboratory testing, cannabinoid extraction and formulation. InterCure serves licensed pharmacies and clinics within Israel and adheres to the regulatory framework established by the Israeli Ministry of Health.

Founded in 2013, InterCure has built a vertically integrated platform that supports both patient care and research initiatives.